Funding for this research was provided by:
Shenzhen Natural Science Fund (20200812115712001)
Article History
Received: 8 June 2022
Accepted: 11 August 2022
First Online: 17 August 2022
Declarations
:
: The study was conformed to the principles outlined in the Declaration of Helsinki. Research ethical committee approval is obtained by the Research Ethics Committee of Health Science Center in a University of China (approval number: PN-202200015). The registration number with the Chinese Clinical Trial Registry is ChiCTR2100053450. Participants were informed that they could back out of the study at any time, and all collected data were processed anonymously and confidentially. The researchers will ask all patients to sign an informed consent. The methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.